Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2020
[Indications and results of radioiodine treatment of differentiated thyroid cancer].
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Riemann B
Аннотация
BACKGROUND: Malignant tumors of the thyroid gland are the most frequent malignant endocrine neoplasms, comprising approximately 1% of all malignant tumors. In recent years there has been a clear rise in the incidence of differentiated thyroid carcinomas (DTC), especially small papillary carcinomas.
OBJECTIVE: Indications for and results of radioiodine treatment (RAI) of DTC.
MATERIAL AND METHODS: A review of the current literature and guidelines of RAI in DTC was carried out.
RESULTS: The use of RAI is the most important adjuvant treatment option for DTC and is generally well-tolerated.
CONCLUSION: Due to the combination of surgery and RAI the DTC has a very good prognosis compared with other cancers, with an average survival rate of more than 90%.
OBJECTIVE: Indications for and results of radioiodine treatment (RAI) of DTC.
MATERIAL AND METHODS: A review of the current literature and guidelines of RAI in DTC was carried out.
RESULTS: The use of RAI is the most important adjuvant treatment option for DTC and is generally well-tolerated.
CONCLUSION: Due to the combination of surgery and RAI the DTC has a very good prognosis compared with other cancers, with an average survival rate of more than 90%.